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Arm lymphedema is a complication following surgery for breast cancer. It varies from 
mild swelling to an incapacitating condition which is associated with numerous risk factors. 
This study is on the incidence of lymphedema among patients after breast cancer surgery in 
our institute. The worldwide incidence of lymphedema varies from 10-60 % (1). This wide 
range is due to difficulty in measurement methods, differential opinion on diagnostic criteria, 
and duration of follow up as well as varying study sample size.  
In breast cancer patients, lymphedema has been described as an often overlooked, 
under diagnosed and undertreated condition, and the same can likely be said for patients with 
other malignancies. It has a major communal effect on physical condition, quality of life, 
functional status, family and finances. 
Many risk factors have been attributed to susceptibility of patients for developing this 
condition. These are individual, disease and management related factors. Obesity, 
hypertension, nodal involvement, axillary dissection, wound infection, chemotherapy and 
radiotherapy are most common ones.(3,4,5,6,7,8). 
The measurement of lymphedema can be done by many ways. The objective 
assessment methods like girth measurement, volume displacement and perometer are utilized 
in incidence and risk factor study commonly (15). Investigations like lymphoscintigrapy, MRI 
are more expensive. The symptoms of lymphedema have been known to develop as early as 
one week to as late as several years after surgery. The reason for varied presentation among 
patients is largely unknown. Most of the patients develop this condition within 3 years after 
surgery. 
It is difficult to predict which patient will end up with this added morbidity. 
Identification of risk factors will enable the health care providers to check lymphedema at an 
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early stage. This study aimed to identify the risk factors to facilitate early detection and 
identification of high risk cases. How each risk factor causes edema, is an unsolved mystery. 
There are no straightforward predictive factors to categorise patients and implement 
measures. To further compound to our problem, the literature gives contrasting data on the 
risk factors associated with lymphedema. Limited work has been done in Indian subcontinent 
and not much data is available on Indian patients. It is difficult to compare western patient to 
an Indian one as the lifestyle and practices are different. 
The most important factor in treating lymphedema is patient compliance. The patient 
can be trained in self care programme to minimise the risk. Also, early referral to 
lymphedema therapists for intervention has been shown to reduce the risk of chronic 
lymphedema and to improve outcomes. The preventive measures like layered bandaging; 
massages can be started early to prevent arm swelling in high risk cases. Preoperative patient 
education, avoidance of intravenous puncture on the affected site and limb care are helpful 
and effective preventive measures. 
The goal of this study is to assess the incidence and risk factors of lymphedema in 
Indian women. This would add to the scarce literature available on Indian patients with breast 
cancer. We intend to improve the standard of care and create awareness among people about 
post mastectomy lymphedema. 
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REVIEW OF LITERATURE 
Lymphedema occurs due to accumulation of protein rich fluid in the interstitial tissue. 
The stagnant lymph causes interstitial inflammation leading to further obstruction of flow and 
thickening of tissues and skin. Lymphedema occurring due to congenital absence of 
lymphatics is known as Primary Lymphedema. Secondary lymphedema happens following 
filarial infections or cancer ablations due to obstruction in lymphatic drainage. Lymphedema 
after breast cancer is the most common cause worldwide although many other cancers are 
associated with the same. The management and long term care plan of both the types is same. 
This condition gravely affects the quality of life. If controlled in initial period, it can improve 
the outcome. This requires great care, commitment and compliance from the patient.  The 
pathophysiology of lymphedema is not well understood but most studied in patients with 
lymphedema following mastectomy. 
 
Anatomy of upper limb lymphatic system. 
The lymphatic system comprises of  
1. Superficial dermal or primary lymphatics and  
2. Secondary lymphatics in subdermal plane.  
The secondary lymphatics are larger and drain the primary lymphatics. These run 
parallel to the superficial veins and drain into lymphatic vessels located in the subcutaneous 
fat adjacent to the fascia. Unidirectional lymphatic flow in secondary and subcutaneous 
lymphatic vessels is aided by muscular wall and valves which are lacking in primary 
lymphatic vessels.  
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There also exists an intramuscular system of lymphatic vessels that parallels the deep 
arteries and drains the muscular compartment, joints, and synovium. The superficial and deep 
lymphatic systems probably function independently, except in abnormal states, although there 
is evidence that they communicate near lymph nodes. The lymphatic vessels of the arm drain 
into ipsilateral subclavian lymphatic trunk and then into subclavian vein. 
 
 
 
Figure 1: Relationship of deep artery, vein and lymphatic channels. 
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The upper limb has a rich lymphatic supply especially the hand. In a digit a pair of 
vessel runs along either side traversing the dorsal surface. They communicate with the palmar 
plexus in the wrist proximally and with the wrist vessels at the medial aspect of the wrist. 
On either surface of the wrist the vessels form the following pattern: 
a) Radial vessels accompanying the cephalic vein, 
b) Median lymph vessel which accompanies median antebrachial vein,  
c) Ulnar lymph vessel accompanying the basilic vein.  
The ulnar vessels terminate in the supratrochlear lymph nodes and the lateral nodes of 
the axilla. The radial vessels drain into the deltopectoral lymph nodes. 
The deep lymphatic vessels of the upper limb accompany the deep arteries (Figure 1). 
They communicate extensively with the superficial vessels. It is drained by the lateral group 
of lymph nodes of the axilla and to the glands along axillary artery. 
13 
 
 
Figure 2: Lymphatic drainage of upper limb 
Axillary Lymph Nodes. 
These important nodes are divided into five groups. 
1. The lateral nodes lie behind the axillary vein and drain the upper limb. 
2. The pectoral nodes, at the inferior border of the pectoralis minor, drain most of the breast. 
3. The posterior, or subscapular, nodes, in the posterior axillary fold, drain the posterior 
shoulder. 
4. The central nodes, near the base of the axilla, receive the lymph from the preceding three 
groups. They form the group most likely to be palpable (against the lateral thoracic wall). 
5. The apical nodes lie medial to the axillary vein and superior to the pectoralis minor. They 
drain all other groups and sometimes the breast directly. The apical group of nodes also 
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empty into two or three subclavian trunks, which enter the jugular-subclavian venous 
confluence, or join a common lymphatic duct, or empty into lower, deep cervical nodes. 
Pathophysiology 
The lymphatic system maintains the fluid homoeostatic mechanism. Tissue edema 
results due to imbalance between fluid generation and the transport capacity of the lymphatic 
channels. This can result due to congenital malformation of lymphatics as in primary 
lymphedema or due to destruction of the lymph nodes / lymphatics in secondary 
lymphedema(16). 
During mastectomy with axillary dissection the lymphatic channels are disrupted due 
to dissection. The tissue inflammation causes fibrosis amounting to obstruction of lymph 
flow. This insult is further exacerbated by radiotherapy, which increases tissue scarring. 
The physiology of lymphedema obeys the ‘Starling law’ (Fig 3). Lymphatics carry 
10 % of the interstitial fluid and the rest is carried by the venous system. The average blood 
capillary pressure equals the colloid oncotic pressure. In the arterial circulation the capillary 
pressure is more than oncotic pressure. This causes ultra filtration leading to increased 
interstitial fluid transfer. On the venous side there occurs re-absorption as the oncotic 
pressure is greater than capillary pressure. The interstitial oncotic pressure and plasma 
oncotic pressure also play an important role to complete the circulation dynamics and 
maintain homoestasis(17). 
The stasis of lymph facilitates interstitial accumulation of protein and cellular 
metabolites. This raises the tissue colloid osmotic pressure causing water accrual and 
elevated interstitial hydraulic pressure. There is associated increase in fibroblasts, adipocytes 
and keratinocytes in the interstitium. These cells are recruited due to presence of cellular 
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metabolites and decreased clearance of lymph. The mononuclear cells initiate chronic 
inflammatory response leading to collagen deposition, overgrowth of connective and adipose 
tissue (18). 
Breast cancer related lymphedema 
Apart from the lymphatic obstruction and destruction there are other factors 
responsible for limb edema as the experiments prove that more tissue damage is required than 
recent surgery. The two probable factors were protein content and vascular factors. It was 
demonstrated by wick technique that protein content of the interstitium of the affected limb 
was lower compared to the normal side. This was probably due to steady state reached by the 
fluid homoeostasis. The vascular mechanism proposed attributing to lymphedema was 
increased angiogenesis leading to raised filtration load(19). 
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Fig 3: Diagram depicting starlings law 
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Clinical features 
It is difficult to predict susceptibility to develop lymphedema after axillary block 
dissection. It starts with apparently normal limb and gradually progresses in severity. Few 
patients develop lymphedema within weeks of surgery where as some take years (20). This 
latent phase may represent a period of balance between existing increase lymph load and 
reduced outflow capacity (21). 
The swelling can affect either a part or the limb completely. Initially the swelling is 
soft with pitting and gradually progresses to indurated, non pitting type with secondary skin 
changes. The precipitating factor is commonly infection but it is incompletely understood. 
The protein rich lymph attracts bacterial growth. This compounded by poor immunity 
worsens the edema causing cellulitis, lymphangitis and further fibrosis involving lymphatics. 
The soft tissue infection can vary from subtle swelling to necrotising infection with systemic 
toxicity. 
The infrequently seen but known complication of long standing lymphedema is 
Stewart - Treves syndrome that is malignant angiosarcoma, lymphoma, melanoma, squamous 
cell carcinoma and Kaposi sarcoma (22). 
The subclinical lymphedema begins with complains of heaviness/ tightness in the 
arm. This progresses to tightness of the regular outfit. The final stage is hyperkeratotic, 
verrucous skin with non pitting edema of the arm. Recurrent episodes of infection worsen the 
condition. Shanton et. al., in 2009 claimed that lymph flow is raised in both the subcutis and 
muscle of both arms in postsurgical breast patients who later developed breast cancer-related 
lymphedema. They also found that there was delayed lymphatic pump failure (21). 
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Stages of Lymphedema 
 The International Society for Lymphology classified lymphedema as (23): 
Stage 0: Subclinical lymphedema: the swelling is not visible in spite of impaired transport. It 
may exist months or years before evident swelling.  
Stage I: Spontaneously reversible: Accumulation of protein rich lymph.  There may be Pitting 
edema which reduces on limb elevation. 
Stage II: Spontaneously irreversible: Pitting mayor may not occur. There is tissue fibrosis 
hence limb elevation does not reduce the swelling 
Stage III: Lymphostatic elephantiasis: pitting is absent with secondary skin changes like 
acanthosis, fat deposits and warty overgrowths. 
Within each stage, a functional severity assessment was also utilized based on volume 
difference assessed as minimal (<20% increase) in limb volume, moderate  
(20-40% increase), severe (>40 % increase). 
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Lymphedema assessment  
There are various methods of diagnosis of lymphedema. The disease is mostly 
diagnosed clinically. The stages of lymphedema are easily determined clinical examination. It 
is the subclinical stage which requires investigations and in cases where cause is uncertain. 
The following table is an easy way to enumerate the variety of investigations available to 
determine and quantify lymphedema. 
Table 1  
Type of assessment  Measure  
Qualitative Lymphangiography 
CT scan 
MRI 
Ultrasound 
Lymphoscintigraphy  
Fluorescence lymphography 
Computed Tomographic  Lymphography 
Quantitative  Circumferential measurement 
Volumetry 
Tonometry  
Quantitative lymphoscintigraphy 
Electric volumetry (perometer) 
Bioimpedance spectroscopy 
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  The qualitative tests are done when the diagnosis or cause is uncertain. These can be 
done to detect additional coexisting condition in the lymphedematous limb like 
lymphovenous malformation. 
Lymphangiography helps in evaluation of lymphatic channels condition in candidates 
planned for lymphatic microsurgery. Here the dermal lymphatic vessels are surgically 
cannulated after intradermal injection of dye. Less invasive techniques like   CT and MRI can 
also be used to measure lymphedema and to characterize the tissue involvement especially in 
malignancy. Lymphoscintigraphy is the gold standard investigation. Its limitation is high cost 
and unavailability in many centres. A radiolabelled tracer is injected in subdermal interdigital 
space of the affected limb. The transport of contrast is monitored with gamma camera to 
visualise the course of lymphatic trunks. Typical abnormalities in lymphedema found are 
absent or delayed transport of tracer, absent or delayed lymph node visualization, crossover 
filling with retrograde backflow and dermal backflow (24). 
The quantitative method helps in objective assessment and categorization of the 
condition. The most common and easy method is by measuring arm circumference at fixed 
levels (25). The limb edema can be calculated using truncated cone geometric calculation. 
Another method is calculation using volume displacement. The amount of water displaced by 
the submerged limb gives the volume of edema fluid. Generally, displacement of more than 
200 ml is designated as lymphedema (26). 
Tissue tonometer measures the pressure required to press the skin. This assesses the 
compressibility of tissues and indirectly lymphedema (27). Perometer utilizes infrared rays to 
measure tissue volume. It is more portable and accurate than water displacement method but 
not as cost effective (28). 
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Multi-frequency bio impedance analyser is the recent instrument to detect and 
quantify early lymphedema. A low ampere current (200-800mAmp) is passed through the 
body. The resistance offered by the tissues which measures the impedance.  The pathological 
accumulation of extracellular ﬂuid is detected by decrease in the measured impedance, in 
ratio to the amount of extracellular ﬂuid accumulation (29). 
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Incidence and Risk Factors 
The incidence of lymphedema has a wide range. It varies from 10-60 %. In 1998, 
Petrek et. al., mentioned the incidence as 6-30 % (30). In a retrospective study at Taiwan, Liao 
et. al., reported the incidence as 8.1% with arm circumference difference more than 2cm in 
570 patients. The incidence of self reported lymphedema was 28% (31). The risk factors of 
lymphedema in their study were identified as radiotherapy and modified radical mastectomy.  
In an audit done by Querci et. al., in 2003, women with axillary level 1and 2 
dissections were observed to have overall incidence of 32.8%. They had divided the limb 
swelling based on region and found differential edema prevalence rate. The risk factors 
attributed were operating surgeon, positive node status for cancer, right side limb and 
dominant limb (32). 
In 2009 Sagen et. al; concluded that physical activity does not cause lymphedema. 
They encouraged patients to start early activity (33). 
A study in India, Deo et. al., in 2004 in their study of 300 patients concluded the 
prevalence rate of 33.5%. Stage of disease, body surface area, loco regional radiotherapy, 
presence of co- morbid conditions and anthracycline based chemotherapy had emerged as 
significant risk factors in univariate analysis whereas axillary radiation and presence of co- 
morbid conditions were significant risk factors for lymphedema development in multivariate 
analysis (34). Pillai et. al., found the incidence rate as 41%. They found correlation between 
increased lymphedema rate and advanced stage of disease, presence of co-morbid conditions, 
and postoperative loco-regional radiotherapy. Axillary irradiation and pathological nodal 
status emerged as significant risk factors for lymphedema (35). 
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In a population based study from Australia, Hynes et. al., reported a overall incidence 
rate of 33% in a 6 to 18 month follow up. The factors associated with increased odds of 
lymphedema were older age, extensive axillary dissection and treatment related 
complications. Patient factors like lower socioeconomic status, having a partner, greater child 
care responsibilities, being treated on the dominant side and participation in regular activity 
were associated with decreased odds ratio (36). 
Clark et. al., found the incidence rate as 20.7% at three year follow up. The 
statistically significant risk factors were skin puncture during hospital stay, BMI more than 
26 and mastectomy (37). 
In large study by Park et. al., in Korea, involving 450 women, the incidence of 
lymphedema was 24.9%. The risk factors responsible were late disease stage, radical axillary 
dissection, radiotherapy and BMI more than 25 (38). 
A large study done by Norman (20) et. al., in 2008 involving more than 600 breast 
cancer patients the cumulative five year incidence was found to be 42%. They have also 
calculated incidence based on severity of lymphedema and time from surgery. The 
cumulative incidence at two and three years was more than 80 %.   In 2010 the author (2), 
studied multiple factors attributed to Breast cancer related lymphedema. According to their 
multivariate analysis, axillary lymph node dissection and anthracycline based multi-agent 
chemotherapy regimens were significantly associated with lymphedema risk. No significant 
risk was found with radiation therapy to chest or axilla, hormonal therapy and type of breast 
surgery. They also did not find any correlation with number of positive nodes.  
In a review by Erickson et. al., in 2001 the estimated incidence was 26%. One in four 
women was suspected to develop lymphedema after breast cancer treatment (39). A meta-
analysis by DiSipio et. al., (40) in 2013 studied their overall incidence rate and it was 
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calculated as 21.4%. The risk factors associated with high level of evidence were axillary 
lymph node dissection, greater number of lymph node removal and obesity. 
Thus, incidence varies depending on the criteria included by the researchers and 
method of determination. The inclusion criteria of many studies vary as some are based on 
telephone conversation where as some have determined by limb circumference using water 
displacement, perometer or girth measurement at different levels. The cut off values to 
distinguish lymphedema also varied author to author.  
It was interesting to note that some studies mention the point prevalence of 
lymphedema. Some patients develop transient swelling in early stage. Devoogdt in 2011 
stated the incidence of breast cancer related lymphedema was around 67-80% in the first year 
after axillary node dissection (6). 
 
Age and risk of lymphedema 
Armer et. al., found that incidence of post mastectomy lymphedema among younger 
patients was high. The incidence was 41% in patients less than 60 years and 30.6% among 
more than 60 years age group (41). 
Coriddi claimed that women more than 50 years had higher risk of lymphedema (47). 
Norman et. al., (2) also found a statistically significant association with lymphedema and 
younger age group. Parbhoo stated that young women are more susceptible as they present 
with aggressive locoregional primary and recurrence. They also have an active lifestyle 
subjecting them to more chances of trauma and infection (42). 
However, according to Helyer et. al., age was not a predictive factor for development 
of lymphedema (43). Herd-Smith et. al., (7) also did not find any correlation between age and 
risk of lymphedema. 
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Socioeconomic status as the factor 
Lower level of education and income had a significant positive association with 
lymphedema according to Norman et. al., in 2010 (2). Hayes et. al., (37) found that lower 
socioeconomic status was associated with decreased odds ratio of lymphedema. Kwan et. al., 
attribute education as a risk factor for breast cancer related lymphedema (45). 
 
Side of the disease  
There was no correlation found between risk of lymphedema and dominant side of the 
patient (13). Herd – Smith claimed increased incidence on left side compared to right side (7). 
Querci et. al., found increased risk on the right side and dominant side (32). They also 
suggested that volume of dominant arm is 3-9% greater than non dominant arm. Even Mak 
et. al.,, in a study in honk Kong found increased risk on the dominant side due to chances of 
trauma (44). In same study by Hayes et. al., (37) said that dominant side was associated with 
decreased odds ratio of developing lymphedema. 
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Body mass index (BMI) 
Obesity and BMI more than 25 is associated with high risk of developing post 
mastectomy lymphedema. (1,2,3,8,10,38,44,45). In the Indian study in AIIMS by Deo et. al., (34) 
expresses increase in body surface area as risk factor. However, Pillai (35) et. al., do not 
mention regarding weight and BMI in their study. An exclusive study done by Helyer et. al., 
(43) on obesity, insisted that obesity is associated with high odds ratio of developing 
lymphedema.  
Herd - Smith (7) found poor correlation with body mass index and lymphedema.  
 A study done in china by Huang in 2013 listed risk factors as obesity, age and 
radiotherapy (46). Coriddi et. al., (47) although studies obesity as the risk factor for 
lymphedema but concludes that it did not contribute to the increased severity of the 
condition. Ridner in a longitudinal study determined that obesity is a risk factor for 
lymphedema but post operative weight gain is not (48). 
 In a univariate analysis by Swenson et. al., in 2009 implied that overweight patient 
were more prone to have axillary radiation, mastectomy, chemotherapy, more positive nodes, 
fluid aspirations after surgery, and active cancer status (49). 
Weight reduction helps in reducing the risk of lymphedema (50). In a randomised 
controlled trial by Shaw et. al.,, they demonstrated weight reduction with low energy intake 
in diet itself lowered risk of lymphedema (51). 
Obesity also predisposes the patient to other comorbidities like hypertension, 
increased chances of infection. They are also susceptible to recurrence and poor prognosis. 
Obesity is also a risk factor for many other forms of cancer like colon, prostrate. Mechanism 
amounting to reduced prognosis among obese are adipose tissue-induced increased 
concentrations of estrogens and testosterone, insulin, bioavailable insulin-like growth factors, 
leptin, and cytokines. Additional proposed mechanisms include reduced immune functioning, 
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chemotherapy dosing, and differences in diet and physical activity in obese and nonobese 
patient (52). 
Shon et. al., reported 5 cases of angiosarcoma in patients with post mastectomy 
lymphedema in morbidly obese patients (53). 
Weight gain after surgery is another indicator of lymphedema according to many 
studies (5, 70).  
 
Pre-operative upper limb morbidity 
Morbidity in the form of previous injury, arthritis or infection of the upper limb of the 
side affected by breast carcinoma is a predisposing factor for lymphedema. It has been 
postulated and in some cases proven by studies that patients with prior upper limb morbidity 
of the affected side are at a higher risk of developing arm swelling after surgery (2,3,54). Mak 
et. al., (44) demonstrated increased odds ratio of developing moderate to severe edema in 
patients with previous inflammation- infection of the ipsilateral upper limb. 
 The mechanism is that these patients have disrupted lymphatics due to prior injury. 
Women with arthritis manifest lymphedema as they exercise less due to pain. Sagen et. al., in 
their randomised controlled trial proved that post operative exercise does not predisposes to 
lymphedema, rather it may be beneficial to the patient and improve outcome (33). 
 Springer et. al., in another study studied that preoperative and early physiotherapy 
with shoulder movement assessment with follow up helped in early diagnosis of  
lymphedema (55). 
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Hypertension and comorbid conditions  
Comorbidities especially hypertension has a strong penchant for lymphedema. The 
increased hydrostatic pressure causes filtration of fluid and reduced capillary absorption 
further causes accumulation of fluid in intersitium. Comorbid condition was found to be 
predisposing factor for lymphedema according to Deo et. al., (34). However Pillai et. al., do 
not mention this factor in their study (35).  Norman (2), Armer (3) have included comorbid 
condition in their risk factor evaluation but did not relate it as the risk factor for lymphedema 
as per analysis. Rockson (13) in his review article considers hypertension as a pertinent risk 
factor secondary to axillary surgery and high dose radiation therapy.  
 Ridner et. al., in a community based study comprising 64 women concluded that 
breast cancer patients were older with pre-existing comorbid conditions, taking medications 
causing fluid retention. This may be a risk factor for lymphedema after breast cancer (56). 
 Meeske et. al., in a study comparing black and white women affected with breast 
cancer related lymphedema showed that hypertension was a risk factor for lymphedema in 
spite of racial difference (57). 
 Soran et. al., (58) had included multiple conditions like hypertension, hypothyroidism 
etc as risk factor but no significant correlation was found. 
 
Extent of surgery and lymphedema  
The radical surgery is associated with lymphedema incidence. It involves the extent of 
lymphnode dissection and even surgeon factor. The radical surgery is known to disturb the 
lymphatic drainage pathway. The number of nodes removed at the time of surgery has a 
positive correlation with development of lymphedema.  The number of nodes involved by the 
disease, however, has mixed results according to various authors. 
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 According to Schunemann et. al., the prevalence of lymphedema after radical, 
modified radical and breast conservation surgery was 39 %, 24 % and 9% respectively (59). 
Deo et. al., did not find any statistical significance between extent of surgery, axillary 
clearance and lymphedema (34). Most of the patient presentation was with advances stages 
requiring axillary clearance.  They claim that post operative radiation to the axilla was 
responsible for the development of lymphedema rather than level of clearance. Pillai et. al., 
reinforced the fact that axilla radiation was responsible for arm swelling. This effect is 
compounded by node positivity. 
 Kwan compared many ethnic groups and found that women with breast cancer related 
lymphedema had more lymph nodes removed and positive nodes irrespective of the ethnicity. 
They calculated that with every single node removal the risk of lymphedema increases to 
4.1%. They also observed risk of edema was more with axillary node dissection compared to 
sentinel lymphnode biopsy (45). 
 Rockson in his review states that it is the extent of axillary dissection and not the 
lymph node involvement responsible for lymphedema (13). This was substantiated by Norman 
et. al., in 2010 in a comparison with breast conservation surgery (2). Another review by 
Coriddi et. al., similarly found increased incidence with axillary lymph node dissection (47). 
Rovere et. al., in 2003 observed higher incidence with level III dissection compared to 
level I and II. The lymphedema associated with level I and II dissection led to localised limb 
swelling. Hence they recommended site specific limb measurement. They further stressed on 
the fact that preoperative and post operative limb measurements were an accurate tool to 
follow up these patients.  Apart from extent of dissection, they also found node positivity and 
dominant side was a significant edema contributing factor (32). 
 Hayes et. al., demonstrated that extensive surgery increased the risk to six fold where 
as removal of more than 20 lymph nodes increases the risk to four fold independently (36). 
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Herd - Smith et. al., said that number of nodes involved was found to be unrelated to 
lymphedema. According to their study removal of more than 30 lymph nodes were associated 
with borderline significant risk of arm swelling (7). 
 Liao et. al., from Taiwan (31) say that number of lymph nodes removed and metastatic 
involvement of nodes did not contribute to lymphedema like Hinrich (8).   
 An interesting study by Purushottam et. al.,(60) revealed inverse ratio between node 
positivity and lymphedema. They proposed that patients with axillary node positive 
undergoing node dissection develop collaterals providing alternative drainage pathways and 
thus reducing lymphedema. 
 
Stage of disease and tumour type 
According to literature the advanced stage was associated with higher risk of 
lymphedema. However, Hinrich et. al., did not find positive correlation between disease stage 
and lymphedema. Norman et. al., compared the stage with chemotherapy and said the 
proportion of women experiencing lymphedema was similar in stages II, III and IV.  
  In the Indian scenario, according to Pillai et. al.,(35) the most common subtype was 
infiltrating ductal carcinoma. The presentation was late 42% locally advanced and 16 % with 
metastasis. They studied that pathological nodal stage III was a significant risk factor. 
 A study in Africa revealed that presentation was generally late. They found that 
greater tumor size, clinically demonstrable axillary nodes, metastasis and locoregional 
recurrence were common. Clinical node positivity, metastasis and recurrent disease were 
independent risk factor of lymphedema (61) 
 Coriddi et. al., reviewed that stage III was associated with risk of upper limb 
symptoms (47). Similar results were obtained by Kwan et. al., (45) and Deo (34). 
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In a study by Rockson the time interval since presentation was an unrelated factor to 
lymphedema (13). 
 Stage of the disease involving tumour histology grade and size determines the 
treatment modality and the regimen; this indirectly influences the risk of lymphedema (3,7). 
The receptor status too has an indirect effect on risk of lymphedema. It influences the 
treatment decision.  
 
Wound drainage and infection 
The common complications after breast cancer surgery are prolonged seroma 
drainage, seroma infection, cellulitis, abscess, wound dehiscence, skin partial or complete 
necrosis and hematoma. This may cause morbidity, and delay chemotherapy, radiation and 
rehabilitation.  
Tadych et. al., concluded that wound drainage more than 900ml had greater than 75% 
rate of arm edema whereas less than 550 ml drainage did not develop lymphedema. The 
mount and duration of drainage did not co-relate with body weight. The persistent and 
seroma and lymphedema was extensive brachial lymphatic destruction. They advised closed 
suction drainage to continue till 24 hours drainage was less than 20 ml (4). 
Fu et. al., in their study involving 130 patients observed that women with 
“symptomatic” seroma had higher risk of lymphedema in future. The symptoms included 
swelling, chest / breast swelling, heaviness, tightness, firmness, pain, numbness, stiffness, or 
impaired limb mobility. He recommended prophylactic preventive measures for such 
groups(62). 
Wound drainage reduced if the tissue handling was gentle along with usage of drain 
and external compression (63). It also reduced the changes of wound infection and dehiscence. 
In the 2013 Cochrane meta-analysis (64) assessing wound drainage after axillary dissection, no 
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significant incidence of lymphedema or hematoma formation was noted was found with no 
drainage. They concluded that quality of evidence was limited to assert the drain insertion 
reduced the seroma formation and aspiration. 
In another systemic analysis by Kuroi et. al., they mention that breast conservation 
surgery reduced the chances of seroma formation. They did not find any strong correlation 
between tumour type with hormone receptor status, stage, volume and duration of seroma 
drainage, amount of negative suction, number of lymph node positive/ removal and use of 
fibrin sealant (65). Hinrichs too declared that postoperative wound infection and duration od 
seroma drainage were not risk factors for lymphedema (8). 
Use of compression bandage around the chest did not reduce the wound drainage and 
of seroma. It rather increased the risk of seroma (66). 
 
Chemotherapy 
Anthracycline based chemotherapy is found to be a risk factor according to many 
observers (2, 34, 57). A hazard ratio of 1.46 was calculated by Norman et. al., for chemotherapy 
causing lymphedema. According to their observation anthracycline based regimen were 
associated with higher risk of lymphedema after chemotherapy.  Coriddi (47) assessed that 
chemotherapy increases the severity of lymphedema. They do not mention the regimen. 
However, Pillai et. al., did not see and significance of chemotherapy causing 
lymphedema statistically (35). No significant association of lymphedema with chemotherapy 
had been proved in a number of studies. A point to note is these studies do not clearly 
mention their regime (8, 31, 32, 69). 
The mechanism of chemotherapy causing lymphedema is not known, The results were 
also confounding according to various studies. It is speculated that chemotherapy is a marker 
for advanced disease and advanced stage is generally associated with lymphedema. 
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The weight gain after chemotherapy is more important risk factor. The 
pathophysiology is not clearly known. Some chemotherapy drug regimen includes steroids 
like dexamethasone which may cause weight gain. The fatigue due to chemotherapy also 
reduces patients’ activity rendering them sedentary. Another reason for weight gain may be 
hormonal changes due to chemotherapy. 
 
Radiotherapy  
Radiation to the post operative site has indication based on stage of the disease and 
the histological nodal status. It is an established cause of lymphedema in the post operative 
period. The risk increases many fold if axillary dissection is followed by radiation. The 
literature has confounding reports on the dosage and region involved. Appropriate planning 
and focussed radiation can reduce the incidence rates of lymphedema. Another factor to be 
considered is the post radiation dermatitis or necrosis. The superadded infection and 
inflammation can precipitate or worsen the condition. The incidence of lymphedema 
secondary to post mastectomy radiation ranges from 0% to 54% (8). 
In the study done by Indian counterparts (34, 35) it was consistent to note that 
locoregional radiotherapy emerged as a significant risk factor leading to arm edema. The 
authors recommend avoidance of axillary dissection with radiation to reduce morbidity. 
Erickson et. al., in their review concluded that axillary surgery with radiation 
increases the chances of lymphedema (39). 
Liao et. al., found a risk correlation between radiotherapy to supraclavicular area and 
axilla. The dosage of radiation did not have an impact on the chances of arm swelling (31). 
Hinrichs et. al., indicated that total dose, posterior axillary boost, overlap technique 
with boost to supraclavicular and internal mammary area resulted in lymphedema. As their 
study was small, multivariate analysis could not be done (8). 
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The various methods to reduce lymphedema following radiotherapy are (67): 
1. To use fractionated dosages (1.8-2Gy/day) total of 45-50 Gy may be used. 
2. In case of supraclavicular radiation it would be better to leave a strip of normal 
skin. This facilitated collateral circulation and reduces risk of lymphedema. 
3. Marking the dissected area with surgical clips to avoid radiation in those 
regions, This is helpful in level III radiation. 
 
MANAGEMENT OF POST MASTECTOMY LYMPHEDEMA  
The aim of treatment is to improve the physical characteristics of the affected limb 
and the quality of life thereby achieving,  
— enhanced social adaptation and a socially useful life,  
— Recovered functional adaptation with physically normal activity, 
— Healthier psychological adaptation despite a psychologically unacceptable physical 
deformity. 
Prior to commencement of therapy it is important to optimise the coexisting 
conditions like hypertension cardiac disease etc. The fluid shift during the therapy may cause 
congestive cardiac failure. 
The treatment can be broadly divided into:  
• Non surgical treatment 
• Surgical treatment 
The gold standard of treatment presently is complex decongestive therapy (CDT) . This 
incorporates various techniques including manual lymphatic drainage, compression devices, 
skin care, therapeutic exercises administered by therapists trained with CDT. It comprises of 
two phases. 
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• Phase I - acute patient management as outpatient setting. It consists of four week 
program of manual lymphatic drainage, short stretch compression bandaging, exercise 
with skin and nail care. 
• Phase II - maintenance at home by patient or family, involves continued proper skin 
care and exercise, self massage and use of a compression sleeve and glove during day 
and bandaging at night.   
Compression bandages gives a pressure of 20-60 mm Hg. The disadvantage is that it 
requires a long term care with change of bandages every six months. Use of compression 
sleeve has not been favourable.  
Therapeutic exercises which include contraction and relaxation of muscles aids in 
drainage of collected lymph fluid. It is advised to do these exercises with the bandage on. 
Manual decongestive therapy is given by a therapist trained in graduated massage form distal 
to proximal region of the limb. This helps in draining lymph and reduces edema. 
Compression bandaging can significantly reduce the edema and has been even proven 
beneficial in preventing lymphedema in high risk cases (5). 
The pharmacological methods of applied are Benzopyrones, flavinoids, diuretics, 
hyaluronidase, pantothenic acis and selenium. The efficacies of these drugs are not 
established yet.  
The surgical options are liposuction, fasciotomy, lymphaticovenous anastomsis and 
superficial lymphangiectomey. These procedures are based on the principles of creating 
alternate route of drainage mainly from dermal to deep lymphatics. Surgery is generally not 
indicated in patients with post mastectomy lymphedema.  
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Measures to prevent lymphedema 
The best way to reduce the incidence of arm edema lies in its prevention. There are no 
randomised controlled trials to prove which method of prevention is effective.  
Treatment strategies to reduce risk like sentinel lymph node dissection instead of axillary 
dissection has been proven beneficial. Detection of lymphedema in subclinical stage with the 
use of bioimpedance spectroscopy can help instituting early measures like compression 
garment or bandage.  
There are certain practices encouraged among the patients to decrease the chances of arm 
edema. The four categories of prevention are  
• Avoidance of  trauma 
• Infection prevention 
• To avoid arm constriction 
• Use of exercise of the limb. 
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AIMS AND OBJECTIVES  
AIM:  
• To study the incidence and factors influencing post mastectomy lymphedema. 
 
OBJECTIVES: 
• To study the incidence of upper limb lymphedema in patients undergoing 
mastectomy. 
• To study the factors responsible for the development of lymphedema. 
• To predict the risk of lymphedema in a patient based on contributing factors after 
immediate postoperative period. 
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MATERIALS AND METHODS 
 
 The research was carried out at the Department of Plastic Surgery and Endocrine Surgery, 
Christian Medical College Hospital, Vellore. The study was approved by the International Review 
Board and ethics committee, Christian Medical College, Vellore. 
Duration of the Study was 1 year and 6 months 
  There was no source of Monetary or Material Support. 
 
Inclusion criteria  
Adult women diagnosed with breast cancer. 
Exclusion criteria  
Males 
Filarial upper limb lymphedema 
Congenital lymphedema or vascular malformations 
Lymphomas involving breast or axilla 
 
Sample size calculated: 80-100 cases 
119 Newly diagnosed cases of carcinoma breast were assessed preoperatively on the 
basis of history, age, co- morbidities especially hypertension and BMI. The women were also 
assessed for any upper limb abnormality like prior injury or shoulder stiffness of the affected 
side. Preoperative measurements of affected upper limb were taken from fixed bony points in 
arm and forearm. The measurement was done using a measuring tape with fixed distance of 5 
cm interval in the arm and the forearm.(fig4)  Distally wrist and the girth of index finger were 
measured. 
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Serial measurement were taken at 1, 3, 6 months and 1 year post surgery. 
  The histopathology was followed for the number of nodes involved and the number of 
nodes removed along with the final stage of the disease. 
In the Postoperative period, patients were assessed on the amount and duration of 
drainage of seroma. They were observed for the signs of infection.  
The proposed treatment was continued. The chemotherapy regimen was noted. The 
effect of radiotherapy on the local area was assessed. 
Patients were assessed for development of lymphedema by serial measurement and 
were broadly separated into 2 subgroups: 
• Without clinical swelling 
• Clinical edema: can be appreciated by the patient easily or increase in size more than 
2cm. 
The patients with edema more than 2cm were diagnosed to have lymphedema.  
 
 
 
Fig 4 : Markings of the measurement 
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The risk factors evaluated were  
1.   Age distribution        
2.   Body mass index        
3.   Comorbidity                    
4.   Hypertension   
5.   Medication           
6.   Socioeconomic status       
7.   Upper limb symptoms    
8.   Laterality of disease side 
9.   Type of surgery 
10. Stage of the disease  
11.       Histopathology 
12.       Node status 
13.       Wound complication                              
14.       Receptor status                                                                         
15.       Seroma dranaage                                    
16.       Duration of seroma drainage                  
17.       Radiotherapy                                          
18.       Chemotherapy                                        
19.       Post radiation skin reaction                    
20.       Post therapy weight gain                        
 
STATISTICAL ANAYISIS  
The statistical analysis was done using Chi Square Test with SPSS version 16. 
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RESULTS 
In this study, total number of patients recruited was 119. Four Patients expired and 12 
were lost to follow up. The total number of patients who completed the study was 103. 
Twenty six patients developed lymphedema over one year thus the incidence of lymphedema 
was found to be 25.24%.Individual risk factors were assessed separately for statistical 
significance as a risk factor.  
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AGE DISTRIBUTION 
 
AGE INTERVAL 
STUDY 
GROUP  
% (n) 
LYMPHEDEMA 
GROUP              
% (n) 
LYMPHEDEMA 
ABSENT            
% (n) 
 
P value 
< 40  years 17.5 (18) 27.7 (5) 72.3 (13)  
 
0.84 
41-60 years 71.8 (74) 25.7 (19) 74.3 (55) 
> 60 years 10.7 (11) 18.2 (2) 81.8 (9) 
 
The common age group was 41-60 years comprising of 74% of the patients. Among the 
women who developed lymphedema, 19 out of 26 women were in the same range. We see a 
trend towards greater number breast cancer among women less than 60 years. 88.5% of 
women who developed lymphedema were younger than 60 years.  However, the age did not 
have a positive statistical correlation as a risk for lymphedema. 
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BODY MASS INDEX 
 
 
 BODY MASS INDEX 
STUDY 
GROUP        
% (n) 
LYMPHEDEMA 
GROUP                
% (n) 
LYMPHEDEMA 
ABSENT                  
% (n) 
 
P value 
 
<25 
  
39.8 (41) 
 
29.3 (12) 
 
70.7 (29) 
 
 
 
 
   
 0.622 
  
  
  
 
25.1-30 
 
36.9 (38) 
 
18.4 (7) 
 
81.6 (31) 
 
30.1-35 
 
18.4 (19) 
 
31.6 (6) 
 
68.4 (13) 
 
               >35 
 
4.9 (5) 
 
20 (1) 
 
80 (4) 
 
Most of our patients were not obese. 76.7 % of women were BMI less than or equal to 30. 
Even in the lymphedema group only one patient had BMI more than 35. Statistically, Obesity 
was not found to be a significant factor. 
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Obesity is not yet a prevalent condition among the lower socioeconomic strata 
from where our patients belong. There is downward trend between number of 
patients and rise in BMI in the study group. The trend was fluctuating type in 
the lymphedema group. 
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COMORBIDITY 
 
 
 
COMORBIDITY 
STUDY 
GROUP        
% (n) 
LYMPHEDEMA 
GROUP                
% (n) 
LYMPHEDEMA 
ABSENT                  
% (n) 
 
P value 
Present 32 (33) 30.3 (10) 69.7 (23)   
0.47 
Absent 68 (70) 22.9 (16) 77.1 (54) 
 
 
Presence of co-morbidity did not correlate with the risk of developing lymphedema. 32 % of 
the women had co- morbid conditions in the form of diabetes, heart disease or renal disease. 
30 % of this group were positive for lymphedema. Among the patients with lymphedema 16 
patients did not have any co-morbid condition. 
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HYPERTENSION 
 
 
 
HYPERTENSION 
STUDY 
GROUP        
% (n) 
LYMPHEDEMA 
GROUP                
% (n) 
LYMPHEDEMA 
ABSENT                  
% (n) 
 
P value 
Present 23.3 (24) 20.8 (5) 79.2 (19)  
 
0.789 
 
Absent 76.7 (79) 26.6 (21) 73.4 (58) 
 
 
 Hypertension was taken as a separate risk factor. Interestingly, in our study it is not a 
significant risk factor leading to limb swelling. 23.3% of the total patients were hypertensive. 
In our study, only 5 women with hypertension developed lymphedema.  
 
 
 
 
 
50 
 
MEDICATION 
 
 
 
MEDICATION 
STUDY 
GROUP        
% (n) 
LYMPHEDEMA 
GROUP                
% (n) 
LYMPHEDEMA 
ABSENT                  
% (n) 
 
P value 
Yes 6.8 (7) 0 100 (7)  
0.187 
  No 93.2 (96) 27.1 (26) 72.9 (70) 
 
 
Many drugs have been held responsible for lymphedema. However, in our study none of the 
patients were found to develop lymphedema who were on medication. 
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SOCIOECONOMIC STATUS 
 
 
SOCIOECONOMIC  
STATUS 
STUDY 
GROUP        
% (n) 
LYMPHEDEMA 
GROUP                
% (n) 
LYMPHEDEMA 
ABSENT                  
% (n) 
 
P value 
Poor 13.6 (14) 35.7 (5) 64.3 (9)  
 
0.538 Middle 85.4 (88) 23.9 (21) 76.1 (67) 
Upper 1 (1) 0 1 (1) 
 
 
Most of the patients were of middle class income group, followed by poor patients. Low 
socioeconomic status was not a risk factor for lymphedema after mastectomy. 
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UPPER LIMB SYMPTOMS 
 
 
UPPER LIMB 
SYMPTOMS 
STUDY 
GROUP        
% (n) 
LYMPHEDEMA 
GROUP                
% (n) 
LYMPHEDEMA 
ABSENT                  
% (n) 
 
P value 
Present 17.5 (18) 27.8 (5) 72.2 (13)   
 
0.771 
 
Absent 82.5 (85) 24.7 (21) 75.3 (64) 
 
 
Patients were evaluated for preoperative upper limb symptoms like pain, arthralgia, trauma or 
previous infection. Only five patients in lymphedema group had preoperative symptoms. 
Most of the women in the study denied any symptoms or history before surgery. Thus there 
was no statistical significance of upper limb symptoms or abnormality and risk of 
lymphedema. 
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LATERALITY OF DISEASE SIDE  
 
 
 
DISEASE SIDE 
STUDY 
GROUP        
% (n) 
LYMPHEDEMA 
GROUP                
% (n) 
LYMPHEDEMA 
ABSENT                  
% (n) 
 
P value 
 
Left 
44.7 (46) 30.4 (14) 69.6 (32)  
 
  0.422  
Right 
49.5 (51) 19.6 (10) 80.4 (41) 
 
Bilateral 
5.8 (6) 33.3 (2) 66.7 (4) 
 
The number of right sided disease was marginally higher than the left side. Six patients had 
bilateral disease. Among the women who developed lymphedema, 30.4% of the study group 
had left sided disease. Two patients had bilateral disease. No correlation was seen between 
side of breast carcinoma and risk of lymphedema. 
 
 
 
 
 
 
54 
 
TYPE OF SURGERY 
 
 
 
SURGERY 
STUDY 
GROUP        
% (n) 
LYMPHEDEMA 
GROUP                
% (n) 
LYMPHEDEMA 
ABSENT                  
% (n) 
 
P value 
 
MRM 
 
95.1 (98) 
 
26.5 (26) 
 
73.5 (72) 
 
 
0.327 
  
BCS 
 
4.9 (5) 
 
0 
 
100  (5) 
 
 
All the patients who developed lymphedema underwent modified radical mastectomy. 95% 
of the patients underwent modified radical mastectomy. Type of surgery was not a risk factor 
for lymphedema. There was no incidence of lymphedema among the patients who underwent 
breast conservative surgery (BCS). However the number was too small to show the 
significance. 
 
 
 
55 
 
 
STAGE OF DISEASE 
 
 
 
STAGE 
STUDY 
GROUP        
% (n) 
LYMPHEDEMA 
GROUP                
% (n) 
LYMPHEDEMA 
ABSENT                  
% (n) 
 
P value 
I 11.7 (12) 16.7 (2) 83.3 (10)  
 
 
 
 
0.483 
 
 
 
 
II 26.2 (27) 14.8 (4) 85.2 (23) 
III 19.4 (20) 35 (7) 65 (13) 
IV 33 (34) 29.4 (10) 70.6 (24) 
TX 9.7 (10) 30 (3) 70 (7) 
 
A wide range was seen in all the stages. 33% belonged to stage IV. Also in lymphedema 
group maximum number was seen in stage IV. This was followed by stage III and then Stage 
II. However, stage of the disease did not have statistical significance as risk factor for 
lymphedema. 
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HISTOPATHOLOGY 
 
 
 
HISTOPATHOLOGY  
STUDY 
GROUP        
% (n) 
LYMPHEDEMA 
GROUP                
% (n) 
LYMPHEDEMA 
ABSENT                  
% (n) 
 
P value 
Invasive ductal 91.3 (94) 25.5 (24) 74.5 (70)  
 
0.393 
 
 
 
Invasive ductal+ TB 3.9 (4) 50 (2) 50 (2) 
Invasive lobular 1.9(2) 0 100 (2) 
DCIS 2.9 (3) 0 100 (3) 
 
The most common tumour type was infiltrating ductal carcinoma 91.3%. There were four 
patients with associated tuberculosis. 50 % of these women developed lymphedema. As the 
invasive ductal type was most common variety of tumour, no statistical significance was 
seen. 
 
 
NODE STATUS 
The mean number of nodes removed 13.06 (0-28). 
The mean number of nodes involved 2.27 (0-17). 
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WOUND COMPLICATION 
 
 
WOUND 
COMPLICATIONS 
STUDY 
GROUP        
% (n) 
LYMPHEDEMA 
GROUP                
% (n) 
LYMPHEDEMA 
ABSENT                  
% (n) 
 
P value 
Present 27.2 (28) 32.1 (9) 67.9 (19)  
 
0.322 
 
Absent 72.8 (75) 22.7 (17) 77.3 (58) 
 
Wound complications like suture line dehiscence, flap necrosis, seroma infection were 
observed for lymphedema. We found that, the incidence of wound complication was 27.2 
percent. Nine women with wound complication developed lymphedema. However, this too 
was proven as a insignificant factor according to statistics. 
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RECEPTOR STATUS 
 
 
 
RECEPTOR STATUS 
STUDY 
GROUP        
% (n) 
LYMPHEDEMA 
GROUP                
% (n) 
LYMPHEDEMA 
ABSENT                  
% (n) 
 
P value 
 
ER/PR Positive 
 
53.9 (55) 
  
 18.2 (10) 
 
81.8 (45) 
 
 
 
 
0.074 
 
 
 
ER/PR Negative 
 
46.1 (47) 
 
34 (16) 
 
66 (31) 
 
 
In this study, the receptor status was not mentioned for one patient. More than 50% of the 
women were estrogen progesterone receptor positive. 16 patients who developed 
lymphedema were receptor negative. Statistically it was not a risk factor but was closely 
related. 
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SEROMA DRAINAGE 
 
 
 
DRAINAGE (ml) 
STUDY 
GROUP        
% (n) 
LYMPHEDEMA 
GROUP                
% (n) 
LYMPHEDEMA 
ABSENT                  
% (n) 
 
P value 
< 500 40.8 (42) 19 (8) 81 (34)  
 
 
 
0.387 
500 -1000 33 (34) 23.5 (8) 76.5 (26) 
1000 - 2000 14.6 (15) 33.5 (5) 66.7 (10) 
> 2000 10.7 (11) 45.5 (5) 54.5 (6) 
 
The amount of seroma drainage was also found not a significant factor causing lymphedema. 
There was an almost equal distribution of quantity of seroma drainage in the women with 
lymphedema 
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There was a rising trend of more drainage among lymphedema group.  As the number of 
subjects were less P value is not significant. 
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DURATION OF SEROMA DRAINAGE 
 
DURATION OF 
SEROMA 
DRAINAGE 
STUDY 
GROUP        
% (n) 
LYMPHEDEMA 
GROUP                
% (n) 
LYMPHEDEMA 
ABSENT                  
% (n) 
 
P value 
5-10 days 30.1 (31) 12.9 (4) 87.1 (27)  
 
 
 
0.181 
 
 
 
 
11-15 days 33 (34) 35.3 (12) 64.7 (22) 
16-30 days 21.4 (22) 22.7 (5) 77.3 (17) 
> 30 days 14.6 (15) 33.3 (5) 66.7 (10) 
 
We did not find the duration of drainage of seroma as a risk factor as its P value was 0.181. 
However, among 15 patients who had a prolonged duration of drainage of more than 30 days, 
5 developed lymphedema. 30% of Patients had seroma drainage for less than 10 days. 15.3% 
(4/26) of patients in lymphedema had duration of drainage less than 10 days. 84.6% had 
drainage more than 10 days. P value on comparing drainage duration more than 10 days and 
less than 10 days was 0.05. This signifies seroma drainage of more than 10 days as risk 
factor. However, more number of patients was required for prove stronger correlation.  
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RADIOTHERAPY  
 
 
   RADIOTHERAPY  
STUDY 
GROUP        
% (n) 
LYMPHEDEMA 
GROUP                
% (n) 
LYMPHEDEM
A ABSENT                  
% (n) 
 
P 
value 
 
No radiation 
 
40.8 (42) 
 
21.4 (9) 
 
80.5 (33) 
 
 
 
0.179 
 
 
Chest + Supraclavicular 
(C+S) 
 
43.7 (45) 
 
22.2 (10) 
 
77.8 (35) 
 
Chest+ Supraclavicular 
+Axilla(C+S+A) 
 
15.5 (16) 
 
43.8 (7) 
 
56.2 (9) 
 
40% of women with breast cancer did not require radiotherapy. This also included the women 
who refused radiotherapy after surgery. 43.7 % underwent radiation to chest and 
supraclavicular area. 15.5% received radiation to axilla as well. 10 out of 26 women who 
developed lymphedema, had their chest and supracalvicular area radiated. There was a rising 
trend towards lymphedema in patients with more extensive radiation.  Statistic significance 
for Radiotherapy as a risk factor for lymphedema could not be demonstrated. 
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POST RADIATION SKIN REACTION 
 
SKIN – POST 
RADIATION 
STUDY 
GROUP        
% (n) 
LYMPHEDEMA 
GROUP                
% (n) 
LYMPHEDEMA 
ABSENT                  
% (n) 
 
P value 
No reaction 33.0 (34) 14.7 (5) 85.3 (29)  
 
 
0.020 
 
 
 
Reaction 26.2 (27) 44.4 (12) 55.6 (15) 
Not applicable 40.8 (42) 19 (8) 81 (34) 
 
Twelve patients developed post mastectomy skin reaction at the radiation site. Out of these 
twelve one patient had skin necrosis. In eight  patients radiation was not given and  five did 
not have any skin complications after therapy. Skin reaction or radiation was statistically a 
significant factor of the risk of lymphedema. 
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CHEMOTHERAPY 
 
 
 
CHEMOTHERAPY 
STUDY 
GROUP        
% (n) 
LYMPHEDEMA 
GROUP                
% (n) 
LYMPHEDEMA 
ABSENT                  
% (n) 
 
P value 
 Nil 11.7 (12) 8.3 (1) 91.7 (11)  
 
0.038 
      Anthracycline 22.3 (23) 8.7 (2) 91.3 (21) 
Anthracycline + 
Taxane 
62.1 (64) 32.8 (21) 67.2 (43) 
Taxane 3.9 (4) 50 (2) 50 (2) 
 
Chemotherapy was found to be a risk factor for lymphedema. Majority of women received 
anthracycline based chemo regimen.  In the lymphedema group, 23 of the 26 patients who 
received anthracycline based chemotherapy. Thus anthracycline based chemo therapy may be 
a risk factor. 
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WEIGHT GAIN 
WEIGHT GAIN STUDY 
GROUP        
% (n) 
LYMPHEDEMA 
GROUP                
% (n) 
LYMPHEDEMA 
ABSENT                  
% (n) 
 
P value 
Yes 9.7 (10)  10 (1)  90 (9)   
   0.445 
  No 90.3 (93)  26.9 (25)  73.1 (68)  
 
 
Only one patient who developed lymphedema after mastectomy had weight gain during 
therapy. This was not found as a risk factor. 93% of the women did not complain of weight 
gain. 
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DISCUSSION 
 
Lymphedema has multiple risk factors associated with it. According to the literature 
no consistent finding is seen pertaining to well defined risk factors responsible for 
lymphedema.  There are many reasons for this inconsistency.  As stated earlier, the method of 
measurement of lymphedema varies from study to study. Another reason was the sample size 
of the study. 
The incidence of lymphedema in our institute was 25.24% in one year. As per Guedes 
Neto the incidence of arm edema within one year of breast cancer treatment was 73% (69). 
The wide range of lymphedema after breast cancer surgery is from 5-60 %. In the Halsteadian 
era, radical surgery led to greater incidence of lymphedema with great morbidity. Evolution 
of advanced diagnostic techniques has led to early diagnosis of the condition. Awareness 
among the women in western country with aggressive screening programmes has also 
contributed to early diagnosis of the disease. According to some studies early stages were 
associated with decreased incidence of lymphedema. This was due to less extensive surgery 
and node dissection. Also in western countries the awareness of lymphedema is widespread 
with multiple lymphedema communities for aftercare and support group. The identification of 
patients at risk of developing lymphedema helps in close follow up with early intervention to 
prevent progression. Many centres provide prophylactic bandages to patients as preventive 
measure. 
The conditions are different in India.  Most of the presentation is late in stage III or 
IV. This leads to extensive node dissection and aggressive post surgical therapy hence they 
indirectly contribute to lymphedema. The awareness among women on lymphedema is low 
and not well understood. In a typical Indian household scenario, many manual activities are 
required. This makes them prone for injuries and thus infection. We educate the women on 
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the postoperative aftercare but we observed that, is not strictly followed by the patients. It is 
said that breast cancer is the disease of working women (2). This finding was refuted in our 
study. Many of our patients were homemakers. The Indian patient is different from a western 
one. Most of the studies have been done on western patients mainly whites. Thus simulation 
of study with application to Indian scenario may not produce similar results.  
The statistical significant risk factors according to our study were chemotherapy and 
skin involvement after radiotherapy. As stated earlier, most of the patients were in stage III 
and IV requiring aggressive chemotherapy and radiotherapy. The common regimen used in 
our institute was anthracycline based. According to Norman et. al., anthracycline based 
chemotherapy was a significant risk factor for post mastectomy lymphedema (2).Similar 
finding was observed with Deo et. al., (34) However in our study the sample size was small. 
Hence many factors which appeared significant could not be proven statistically. 
Majority of the patients who developed lymphedema after radiotherapy had skin 
involvement after radiotherapy in the form of skin necrosis. Two patients developed skin 
necrosis of the post operative radiation site. Al though this variable was significant 
statistically, the larger sample size would have aided in defining the role of regional radiation 
in causing arm edema. Many studies state radiotherapy especially to axilla as a risk factor 
(34,39) . Here it could not be proved statistically. Axillary radiation was avoided unless 
necessary based on tissue and node biopsy status.  
Another factor which seemed weakly significant was receptor status. We found that 
15.5% of the total patients were receptor negative and developed lymphedema. Sixteen of the 
26 patients were negative or Estrogen and progesterone receptors and developed 
lymphedema. As mentioned before, larger sample size would have been better to explain in 
statistical terms. Negative estrogen receptor status as a risk factor for lymphedema has been 
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supported by few studies. The receptor status decides the chemotherapy regimen of the 
patients. Hence it indirectly contributes as the risk factor for lymphedema. 
The age of the patient did not have any strong correlation statistically but we observed 
that most of our women were in the age group of 40-60 years. The incidence of breast cancer 
and  lymphedema was also high among the women less than 60 years. These findings were 
consistent with studies done by Norman (2), Armer (41) and Parbhoo (42). This is due to active 
lifestyle of younger women making them prone to injuries. Another possible reason can be 
aggressive tumour stage and subsequent therapy.  It requires further studies to explain the 
cause of malignancies in early age group in our country.  
Obesity as a factor for lymphedema was refuted as majority of our patients (76%) had 
BMI less than 30. Majority of the women were not overweight or obese.95% of the patients 
had BMI less than 30. Hence there was no statistical significance between obesity and risk of 
lymphedema. As per the Asian study by Liao et. al., (31), the oriental women built is different 
compared to Caucasian women hence they proposed that criteria of diagnosis may change 
according to ethnicity. Similar situation applies to Indian subgroup also. It is difficult to 
restrict criteria as each ethnic subgroup has specific structural composition and lifestyle 
habits. 
Since the women were belonging to middle age group, there were lesser morbidities 
associated. Co - morbid conditions especially hypertension may be risk factor for 
lymphedema (13,34,57,58) . We did not find a statistical significance between comorbid 
conditions, hypertension and lymphedema. Also, majority our patients were not on any 
medications which could contribute to lymphedema.    
Preoperative upper limb symptoms in the form of shoulder pain, restricted movement 
and previous fractures were not found to be risk factor for lymphedema. Most of our patients 
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resume daily activities of self care in early post operative period. Post operative exercise were 
encouraged hence upper limb symptoms were not pronounced among the women after 
mastectomy. 
Side of the disease could not be proven as a risk factor and there was nearly equal 
distribution of carcinoma breast. Only two patients had bilateral disease and had developed 
lymphedema on both sides. Also, their disease was advanced stage. 
The stage of presentation of the patients was generally advanced (62.1%). Ad 
discussed earlier, the advanced stage was associated with lymphedema. 20/26 of the patients 
with lymphedema had advanced disease. This appears a significant factor causing 
postoperative arm edema. The analysis was not consistent with our argument as more number 
of cases was required. The cause of late presentation was due to poor awareness among the 
patients. There was a difficulty in accepting and understanding the condition which delays the 
treatment further. Also the Indian women are hesitant to reveal the problem to the relatives as 
it involves a private area and fear stigmatization. 
The presentation of patient with carcinoma breast was late. The commonest surgery 
performed was modified radical mastectomy. Breast conservation surgery was done for very 
few women. None of the women who developed lymphedema underwent breast conservation 
surgery. However the number was small to show significance. The commonest 
histopathology was infiltrating ductal carcinoma. We had 4 cases of patients with coexisting 
tuberculosis. Out of the 4 patients two developed lymphedema. Poor socioeconomic 
background may be responsible for such condition. The mean number of nodes removed 
13.06.The mean number of nodes involved 2.27. The number nodes removed did not have 
correlation with risk of lymphedema. 
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27% of the patients had wound complications in the form of suture line dehiscence, 
marginal necrosis of the suture line, seroma infection and seroma abcess. 9 out of 26 patients 
had lymphedema with positive history of wound complication. However we need to have 
more patients in the study to prove statistical significance. The most common complication 
was suture line dehiscence. 
The duration and amount of seroma drainage was studied. 40 % of the patients had 
total seroma drainage of less than 500 ml. Duration of drainage was less than 15 days in 63% 
of the patients. Among the lymphedema group there was almost equal distribution of the 
duration and quantity of seroma drainage as the non lymphedema group. The amount and 
duration of seroma drainage was not a risk factor for lymphedema. However on comparing 
drainage less than 10 days and more than 10 days in lymphedema group the P value is 0.05 
indicating if the duration of seroma drainage is more than 10 days it can be a risk factor 
however more number of cases are required to prove a strong correlation.  
40% of the patients did not receive radiotherapy as it was not indicated. 44% received 
radiation to chest and supraclavicular area. This included the patients who received radiation 
to chestwall exclusively. Only 14% of advanced cases received radiation to axilla along with 
chest wall and supraclavicular area. Among the lymphedema group, there was a rising trend 
towards arm edema on increasing the radiated area. More sample size was required to prove 
statistical significance. 
Weight gain after surgery of adjuvant therapy was considered as a risk factor for 
lymphedema (2). However, only one patient had weight gain and developed lymphedema. 
Most of the women in fact lose weight during the course of therapy in our setup. Weight gain 
was observed in only 10% of the patients.  
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The advantage of this study is it encompasses many risk factors which have been 
proposed in various studies. The assessment of swelling was done by single observer thus 
error was reduced. It was a prospective study and patients were on regular follow up. 
The disadvantage is more sample was required. Also there may be patients who 
develop arm edema after one year thus long term follow up would be required. 
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CONCLUSIONS 
 
The incidence of lymphedema according to our institute was 25.24%.  
The risk factors which was statistically significant were anthracycline based chemotherapy 
and  post radiotherapy skin involvement.  
Estrogen receptor status had indirect correlation with lymphedema as it decides the 
chemotherapy regimen. 
Seroma drainage for more than 10 days was also proved to be significant factor statistically. 
There was a rising trend towards radiation to axilla and lymphedema however statistic 
significance was not conclusive. 
Factors like age, BMI, hypertension, comorbid condition, upper limb morbidity, side of the 
disease, histopathology, lymphnode status, stage of the disease, type of surgery, radiation and 
weight gain were not proven as risk factor statistically. More number of patients and longer 
duration of study were required to prove further correlation and significance of factors.  
It is important to consider the ethnicity and cultural habits of the patients while stratifying the 
risk as it is a lifestyle disease.  
Lymphedema is a preventable condition and preoperative lymphedema education can help 
immensely in reducing the incidence as there are ambiguities narrowing the risks in each 
individual.  
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CONSENT FORM FOR PATICIPATION IN THE STUDY 
Arm lymphedema is a common problem seen in patients following surgery for breast cancer. 
It is a debilitating condition which is associated with certain risk factors. This study is about 
finding out the incidence of lymphedema among patients after breast cancer surgery. We will 
also study  some parameters like weight, infection etc which may be responsible for the 
development of lymphedema and the attributable risk factors. 
The patient will be assessed preoperatively with weight and height and limb measurement . 
Measurement of the limb will be done with a measuring tape and bioimpedance analyser to 
look for fat content and water content of the limb and body. The patient will be monitored 
after surgery for the amount of collection in the drain, wound infection, type of cancer of the 
breast. She will undergo usual treatment of breast cancer like surgery, chemotherapy and 
radiotherapy. She will have to follow up regularly at 1 month, 3 months, 6 months and 1 year 
after surgery for measurement . If she feels any tightness of the arm or heaviness she will 
have to contact immediately. 
The duration of study is 1 year. 
There are no risks or discomfort or benefits involved in participating in the study. 
The patients information and identity will be kept confidential and will be accessed only to 
the investigators. 
Participation in the study is totally voluntary and patient can withdraw any time she wishes to 
do so. 
There will be no compensation paid in view of any complications during the treatment. 
If there is any significant finding during the study, the patient will be informed about further 
course of treatment or intervention required. 
Approximate number of participants in the study: 100 women. 
Understanding the above facts, I give my consent to participate in the study. 
Name of the participant: 
Sign  
Date  
Place : 
Name and sign of witness  
Name and sign of person taking the consent: 
 
84 
 
Proforma 
1. Name  
2. Age  <40 yrs, 40-60 yrs, >60 yrs 
3. Occupation 
4. Hospital number 
5. Weight 
6. Height 
7. Body mass index  <25,  25-30,  30-35,  >35 
8. History of injury to the upper limb previously: yes/ no 
9. Hypertension  yes/ no 
10. Comorbid condition 
11. Family history of breast cancer   Y/N 
12. Arthritis      Y/N 
13. History of lymphedema in family  Y/N 
14. History of lymphedema in family member affected with carcinoma breast  y/n 
15. Medications causing fluid retention?  Y/N 
16. Education level: < highschool, college graduate, post graduate, professional 
17. Marital status: married, divorced, widow, unmarried, never married  
18.  Socioeconomic status: poor/ middle/ upper class 
19.  Side: left/right/ bilateral 
20. Stage of the disease:    
21. Metastasis present:  Y/N 
22. Shoulder pain or difficult mobility preoperatively: Y/N 
23. Upper limb deformity on the affected side Y/N 
24. Range of movements of shoulder joint normal/ abnormal 
25. Date of surgery 
26. Level of axillary dissection 
27. Type of tumour (histology) 
28. Grade of tumour : well, moderately, poorly  differentiated 
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29. Number of nodes in the specimen identified 
30. Number of nodes in the specimen involved. 
31. Er/pr status: positive/ negative 
32. Seroma: main wound: yes/no 
33. Seroma: axilla: yes/no    if yes then is it < 10ml or >10ml? 
34. Wound infection:  
• Skin 
• Skin and subcutaneous tissue 
• Seroma infection 
• Lymphangitis  
36 Total drain output: (all drains under flap and in axilla plus seroma aspiration 
< 500 
500-1000 
1000-2000 
>2000 
 
37 Date/ day of drain removal and seroma stoppage 
 5-10 days,  
10-15 days, 
 15-30 days 
>30 days 
38 Preop chemotherapy yes/ no 
39 Post op chemotherapy: how many cycles? 
40 Drugs given: 
41 Anthracycline based chemo   yes/ no 
42 Radiotherapy:                    Dosage : 
• Nil 
• Chest wall 
• Chest wall + supraclavicular field 
•  Chest wall + supraclavicular field+ full axilla 
 
 
43 Weight gain during or after treatment : y/n 
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44 Measurement 
 
Limb girth Pre op 1 month 3 months 6 months 1 year 
Arm 5cm      
Arm 10cm      
Arm 15      
Arm 29      
Forearm 5      
Forearm 10      
Forearm 15      
Forearm 20      
Wrist       
Index finger       
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Master chart Code Book 
 
Age 
 
1. <40 
2. 40-60 
3. > 60  
Upper limb abnormality 1. Yes 
2 No 
Comorbid condition 1. Yes 
2 No 
Hypertension 
 
1. Yes 
2 No 
Medication 
 
1. Yes 
2 No 
Marital status  
 
1. Married 
Socioeconomic status 
 
1. Poor 
2. Middle 
3. Upper 
Side of the disease 
 
1. Left 
2. Right 
3. Bilateral 
Surgery 1. MRM 
2 BCS 
Histoplathology (HPE) 
 
1.  invasive ductal 
2. invasive ductal +tuberculcosis 
3. invasive lobular 
4. ductal carcinoma in situ 
Stage of the disease 1. Stage I 
2. Stage II 
3. Stage III 
4 . Stage IV 
5. Tx 
ER/PR status 
 
1. Positive 
2. Negative 
Wound Complication 
 
1. Yes 
2 No 
Duration of seroma drainage 
 
1. 5-10days 
2. 10-15days 
3. 15-30days 
4. >30days 
Amount of seroma drainage (ml) 
 
1. <500 
2. 500-1000 
3. 1000-2000 
4. >2000 
Chemotherapy 1. Nil 
2. anthracycline only 
3. anthracycline +taxane 
4. taxane 
5. taxane+ 2nd line chemo 
6. Not Known 
Radiotherapy 1. Nil 
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 2. chest wall 
3. chest wall +supraclaviclular area 
4. chest wall +supraclaviclular area+ axilla 
Skin 
 
1. no reaction 
2. reaction 
3. necrosis 
4. Not applicable 
Lymphedema  
 
1. yes 
2. no 
Weight gain 
 
1. yes 
2. no 
 
 
 
 
 
 
 
sno NAME HOSP. NO. AGE
WEIGH
T HEIGHT BMI
UPPER LIMB 
ABNORMALITY
COMORBI
D
HYPERT
ENSION
MEDICATIO
N
MARITAL 
STATUS
SOCIOECONOMIC 
STATUS SIDE SURGERY HPE STAGE
NODES 
REMOVED
NODES 
INVOLVED
ER/
PR
WOUND 
COMPLI
CATION
DURATION 
OF 
DRAINAGE
SEROMA 
COLLECT
ION
CHEMO RADIO THERAPY
SKIN 
INVOLVE
MENT
LYMPH
EDEMA
WT. 
GAIN
1 akidan khatoon 115841f 2 65 152 28.1 2 2 2 2 1 1 1 1 1 4 3 2 1 1 3 2 3 1 4 2 2
2 amina khatoon 209081f 2 77 165 28.3 2 2 2 2 1 2 2 1 1 5 28 0 1 2 2 4 3 3 1 2 2
3 anjala 117656f 2 75 149 33.8 2 2 2 2 1 2 2 2 1 3 11 2 1 2 1 1 3 1 4 2 2
4 anju bibi 167530f 1 52 150 23.1 2 2 2 2 1 1 2 1 1 1 5 0 2 2 3 1 3 1 4 2 2
5 arti das 19194f 2 50 150 22.2 2 1 2 2 1 2 1 1 1 4 9 7 1 2 4 2 3 4 1 2 2
6 baby saha 243219f 1 65 150 28.9 2 2 2 2 1 2 2 1 1 1 11 2 1 1 1 1 3 3 1 2 2
7 bahnumathy 171441f 2 59 144 28.4 2 1 1 2 1 2 2 1 1 4 10 0 2 2 1 1 3 1 4 2 2
8 banu 114220f 2 44 143 21.5 1 2 2 1 1 2 2 1 1 2 7 0 1 2 3 2 2 1 4 2 1
9 bhavani 746733c 2 48 150 21.3 2 1 2 2 1 2 1 1 1 1 11 0 1 2 2 2 2 1 4 2 2
10 bimal sinha 153842f 2 89 158 35.7 2 1 1 1 1 2 1 1 1 2 15 3 2 1 2 3 3 3 2 2 2
11 bimala jana 108652f 2 34 139 17.6 2 2 2 2 1 2 1 1 1 2 16 1 2 2 1 1 1 2 1 2 2
12 chandrika devi 113857f 1 60 152 25.9 2 2 2 2 1 2 1 1 1 2 15 0 1 2 1 1 2 2 1 2 2
13 devaki 124100c 2 73 154 30.4 2 1 2 2 1 2 1 1 1 4 18 0 2 2 2 2 3 1 4 1 2
14 dulsie 069389f 2 79 159 31.2 1 2 2 2 1 2 2 1 1 5 13 10 1 2 1 1 3 3 2 2 1
15 elsamma 235916f 2 65 150 28.8 2 2 2 2 1 2 1 2 1 1 14 0 2 1 1 1 3 1 4 2 2
16 geeta 065307f 2 73 153 31.2 2 2 2 2 1 2 2 1 1 4 19 0 1 2 1 2 2 3 2 2 2
17 geetanjali 127537f 1 35 143 17.1 2 2 2 2 1 2 2 1 2 4 0 0 2 1 1 1 3 4 2 1 2
18 grace nirmala 167699f 2 81 147 37.5 2 2 2 2 1 2 2 1 1 2 14 0 1 2 2 2 3 1 4 2 2
19 gracy 486104c 3 70 152 30.3 1 1 1 1 1 2 1 1 1 1 11 0 1 2 1 2 1 1 4 2 2
20 guddi singh 172644f 1 48 153 20.5 2 1 2 2 1 2 1 1 1 4 13 0 NA 2 1 1 3 3 1 2 2
21 hafisa 670732b 1 61 167 21.9 2 2 2 2 1 2 1 1 1 3 19 4 1 2 3 3 3 4 2 2 1
22 hilda SR 164439f 2 64 161 24.1 2 1 2 2 1 2 B 1 1 3 15 0 1 2 2 3 3 3 2 1 2
23 himambee 1439998f 1 60 150 26.7 2 2 2 2 1 2 1 1 1 4 14 9 2 2 2 1 5 3 2 1 2
24 isha bee 502592 2 58 148 26.5 2 1 1 2 1 2 1 1 1 3 14 0 2 1 4 4 4 3 2 2 2
25 jalaseeshu kumari 155524f 2 25 155 27.5 2 2 2 2 1 2 B 1 1 4 6 3 2 2 4 4 3 3 1 2 1
26 jyotsna saw 183754f 2 48 150 21.3 2 2 2 2 1 1 1 1 1 4 9 6 2 2 4 2 2 1 4 2 2
27 kabita sen 148571f 2 73 155 30.4 2 1 1 1 1 2 1 1 1 4 7 2 1 2 3 3 1 3 1 2 2
28 kamalam 125132f 2 52 154 21.9 2 2 1 2 1 1 2 1 1 2 17 2 1 2 2 1 3 1 4 2 2
29 kanchan moni 134735f 2 80 141 40.2 2 2 2 2 1 2 2 1 1 2 13 1 1 1 1 1 1 2 1 2 2
30 kasturi 176717f 2 67 151 29.7 1 1 1 2 1 2 2 1 1 4 10 2 2 1 1 1 3 3 1 2 2
31 kavikarasi 230653f 3 64 145 30.4 2 2 1 2 1 2 2 1 1 1 14 14 1 1 3 2 2 1 4 2 2
32 lalawati devi 125528f 1 35 145 17.5 2 2 2 2 1 2 B 1 1 4 10 2 1 1 2 1 3 3 1 2 2
33 laxmi d 226771f 1 54 154 22.8 2 2 2 2 1 2 1 1 1 5 10 0 2 2 1 1 1 1 4 2 2
34 laxmi devi 116399f 2 48 141 24.4 2 2 2 2 1 1 2 1 1 4 16 0 2 1 2 1 2 3 3 2 2
35 laxmirani paul 193313f 3 60 148 27.4 1 2 2 2 1 2 2 1 1 2 14 1 1 2 2 2 6 1 4 2 2
36 madhanlane 176276f 2 82 152 35.5 2 2 2 2 1 2 1 1 1 4 9 1 2 1 3 4 3 1 4 1 2
37 malarkodi 087995f 2 48 148 21.9 2 1 1 2 1 1 1 1 1 3 8 0 2 2 1 1 3 3 1 1 2
38 mangalaxmi 181941f 2 57 151 25.9 2 1 2 2 1 2 2 1 1 2 19 0 1 2 3 2 1 1 4 2 2
39 manjula 093547f 2 60 160 23.4 2 2 2 2 1 1 1 1 1 5 15 1 2 2 1 1 3 4 1 1 2
40 margatham 153714f 2 55 150 24.4 1 2 2 2 1 2 2 1 1 5 25 6 1 2 2 2 3 4 2 1 2
41 mariyamma 186846f 3 74 147 34.2 2 2 1 2 1 2 1 1 1 5 11 11 2 1 3 4 2 1 4 1 2
42 mary kujur 238886f 2 62 149 27.9 2 2 2 2 1 2 2 2 1 2 7 2 1 2 2 1 3 4 2 2 2
43 meena 092279f 2 53 148 24.2 2 1 2 2 1 1 B 1 2 2 7 0 2 2 1 2 3 1 4 1 2
44 meena singh 979083d 2 76 156 31.2 2 2 2 2 1 2 2 1 3 3 16 16 1 2 4 4 3 1 4 2 2
45 meller baby 226029f 2 56 152 24.8 2 1 1 2 1 2 2 1 1 1 10 0 1 2 2 2 1 1 4 1 2
46 mercy 210754b 2 55 154 23.2 2 1 2 2 1 2 2 2 1 2 13 0 1 2 1 1 2 3 1 2 2
47 minnala devi 033426c 2 54 150 24 2 1 2 2 1 1 1 1 1 2 17 0 1 2 3 1 2 2 1 2 2
48 minu barikh 181686f 2 49 150 21.7 2 2 2 2 1 2 1 1 1 4 5 5 1 2 2 1 2 3 1 2 2
49 mita palit 225023f 2 64 156 26.3 2 2 1 2 1 2 B 1 1 1 13 1 1 2 1 2 3 2 1 2 2
50 nalini mary 995074c 2 63 145 29.9 2 2 2 2 1 2 2 1 4 3 21 0 2 2 2 2 2 3 1 2 2
51 namita saha 153494f 2 50 140 25.5 2 1 2 2 1 2 1 1 1 2 12 0 2 1 1 1 2 1 4 2 2
52 neelam 193821f 1 55 144 26.5 2 1 2 1 1 2 1 1 1 4 8 0 2 2 1 1 3 4 1 2 1
53 nimbal 923703d 2 56 144 26.6 1 1 1 2 1 2 1 1 1 3 13 0 2 2 2 1 3 3 1 2 2
54 padmini 351427d 2 65 155 27.1 2 1 2 2 1 2 1 1 1 3 16 0 2 1 2 2 4 3 3 1 2
55 parimala 447930c 2 66 163 24.8 2 2 2 2 1 2 2 1 1 4 9 1 1 2 2 1 3 3 1 2 2
56 parul das 224019f 2 52 144 25 1 2 1 2 1 2 1 1 1 2 24 0 2 2 2 2 3 1 4 2 2
57 philo francis 195844f 2 55 139 28.5 2 2 2 2 1 2 1 1 1 2 18 6 1 2 3 1 3 4 2 2 2
58 poly chopra 104100f 1 68 152 29.4 2 2 2 2 1 2 2 1 1 4 7 0 2 1 2 1 3 3 1 1 1
59 prabhavati devi 047680f 2 60 145 28.1 2 1 1 1 1 2 1 1 2 2 20 17 1 2 3 2 1 3 1 2 2
60 prema 205877f 3 65 157 23.3 2 1 2 1 1 2 2 1 1 4 16 8 1 2 4 4 3 3 2 2 2
61 promila saha 192579f 2 60 144 28.9 1 2 2 2 1 2 2 1 1 5 21 2 1 1 2 1 3 3 2 2 2
62 radha 125212f 3 54 145 25.7 2 2 2 2 1 2 1 1 1 4 9 0 1 2 1 2 2 1 4 2 2
63 rajeshwari 368594a 3 62 155 25.8 2 2 1 2 1 2 2 1 4 1 23 0 1 2 2 2 1 1 4 2 2
64 rajeshwari R 142639f 2 56 145 26.6 2 2 2 2 1 2 1 1 1 5 16 0 2 2 2 1 3 3 1 2 1
65 ramadevi 233341f 2 66 160 25.8 1 1 1 2 1 3 2 1 1 1 7 2 1 2 4 4 3 4 2 2 2
66 ratna sarcar 186521f 2 65 154 27.4 2 2 2 2 1 2 2 1 1 3 10 0 2 1 3 3 3 1 4 2 2
67 renuga 192113f 2 65 151 28.5 2 1 1 2 1 2 1 1 1 3 19 0 2 2 2 2 3 1 4 1 2
68 sabita S 030494f 1 49 156 20.9 2 2 2 2 1 2 1 1 1 4 8 0 1 2 1 1 3 3 1 2 2
69 sandhya majumda 232278f 3 71 153 30.3 2 2 1 2 1 2 2 1 1 4 23 9 1 2 3 3 1 1 4 2 2
70 santu nath 149857f 2 68 157 27.6 1 2 2 2 1 2 2 1 1 4 10 2 1 2 1 2 3 4 1 2 1
71 saroja 176457f 2 81 147 37.5 2 2 2 2 1 2 2 1 1 2 13 0 1 1 4 3 2 1 4 2 2
72 sayba bairagi 221590f 2 43 138 22.6 2 2 2 2 1 2 2 1 1 2 12 0 1 2 2 1 2 1 4 2 2
73 selvi 900987d 2 54 150 24 2 2 1 2 1 1 1 1 1 3 7 7 2 1 3 2 3 3 1 2 2
74 shantakumari 145517f 2 56 155 23.5 2 2 2 2 1 2 2 1 1 3 19 0 2 2 3 3 2 4 1 2 1
75 shanti P 125264f 1 70 147 32.4 2 2 2 2 1 2 2 1 1 3 5 0 1 2 4 3 3 3 1 1 2
76 shantikumari 138679f 1 67 147 33.2 2 2 2 2 1 2 2 1 1 3 20 0 2 2 2 2 4 1 1 2 2
77 shashi mishra 131207f 3 62 157 25.2 2 1 2 2 1 2 2 1 1 5 13 1 1 2 1 1 2 3 1 2 2
78 shibani biswas 106810f 2 62 152 26.8 1 1 2 2 1 2 B 1 1 3 7 4 1 1 4 2 3 4 2 2 2
79 shibani ghosh 239901f 2 63 152 27.3 2 2 2 2 1 2 1 1 2 2 15 3 2 2 1 1 3 3 1 2 2
80 srilaxmi 150744f 2 49 152 20.8 2 1 1 2 1 2 2 1 1 4 20 1 2 2 3 3 3 3 1 2 2
81 sunderammal 321514c 3 59 148 26.9 2 2 2 2 1 2 1 1 1 3 17 7 2 2 3 2 3 3 2 1 2
82 sushila 393046c 2 77 158 30.8 2 2 2 2 1 2 2 1 1 2 17 0 1 2 2 2 2 1 4 2 2
83 vijayaprabha 129795f 2 70 152 30.3 1 2 2 2 1 2 2 1 4 2 17 0 2 2 4 3 3 3 2 2 2
84 yasoda 224881f 3 90 163 33.8 2 1 2 2 1 1 1 1 1 1 13 0 1 1 3 3 2 1 4 2 2
85 parul rani 090792f 2 50 150 25 2 2 2 2 1 2 1 1 1 5 15 0 2 2 1 1 1 1 1 2 2
86 phulmaya 086846f 2 52 143 25.4 2 2 1 2 1 2 2 1 1 4 15 10 1 2 1 2 3 1 1 2 2
87 bijoylakshmi 181018f 2 40 147 18.5 2 2 2 2 1 2 2 1 3 2 2 0 2 1 1 1 2 1 4 2 2
88 hasina khan 975366c 2 62 158 24.8 1 1 2 2 1 2 2 1 1 1 23 0 2 2 4 4 3 1 4 1 2
89 biva ghosh 150071f 2 49 150 21.8 2 1 2 2 1 2 2 1 1 4 2 0 2 2 3 1 2 4 1 2
90 madhabi pal 268958f 2 55 156 22.6 1 2 2 2 1 2 2 1 1 3 18 8 1 2 4 4 3 4 2 1 2
91 manju sadhukhan 216765f 2 46 150 20 2 2 2 2 1 1 2 1 1 3 18 3 2 2 2 1 3 1 4 2 2
92 kanammal 960351b 2 68 148 31 2 2 2 2 1 1 2 1 1 2 17 1 2 2 2 1 3 3 2 1 2
93 karthika 178494f 1 65 148 30 2 2 2 2 1 2 2 1 1 3 13 0 2 2 3 2 3 2 1 2 2
94 jasmin 233260f 2 86 160 33.6 2 1 1 2 1 2 2 1 1 2 6 3 2 2 4 4 3 4 2 1 2
95 rama das 137462f 2 50 150 22.2 2 2 2 2 1 2 1 1 1 4 12 5 1 1 2 1 3 4 2 1 2
96 priya barnwal 224111f 1 66 150 29.3 2 2 2 2 1 2 1 1 1 4 6 3 1 1 3 3 3 3 1 1 2
97 sunaina giri 342428c 2 75 150 33.3 2 1 1 2 1 2 2 2 1 2 4 0 1 2 NIL NIL 2 2 2 2 2
98 sunaina sahani 093006f 2 70 155 29.1 1 2 2 2 1 2 1 1 1 4 8 1 1 2 4 2 3 3 2 1 2
99 susama bose 243989f 2 51 144 24.6 2 2 2 2 1 2 1 1 1 4 21 2 1 1 2 3 3 4 2 1 2
100 anjana ray 253790f 1 40 153 17 1 2 2 2 1 2 1 1 1 4 12 10 2 1 1 2 3 1 4 2 2
101 umarani 330221f 2 74 155 30.8 1 2 2 2 1 1 1 1 1 2 14 0 1 1 2 3 3 1 4 1 2
102 selvi k 085009d 2 50 147 23 2 2 2 2 1 2 1 1 1 4 16 0 2 2 2 2 3 1 4 2 2
103 preeti 277009f 1 57 154 24 2 2 2 2 1 2 1 1 1 4 12 2 2 2 1 1 3 3 2 2 1
